Literature DB >> 23382603

T-cell prolymphocytic leukemia.

Robbie L Graham1, Barry Cooper, John R Krause.   

Abstract

T-cell prolymphocytic leukemia is a rare and unusual malignancy characterized by the proliferation of small- to medium-sized prolymphocytes of postthymic origin with distinctive clinical, morphologic, immunophenotypic, and cytogenetic features. Involvement of the peripheral blood, bone marrow, lymph nodes, liver, spleen, and skin can occur. The clinical course is typically very aggressive with poor response to conventional chemotherapy and short survival rates, and the only potential long-term curative treatment is hematopoietic stem cell transplantation. We report the case of a man with de novo T-cell prolymphocytic leukemia and discuss the distinctive clinical, morphologic, immunophenotypic, and cytogenetic features of this entity.

Entities:  

Year:  2013        PMID: 23382603      PMCID: PMC3523759          DOI: 10.1080/08998280.2013.11928902

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  25 in total

Review 1.  T-cell prolymphocytic leukemia.

Authors:  Claire E Dearden
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

Authors:  R Pawson; E Matutes; V Brito-Babapulle; H Maljaie; M Hedges; J Mercieca; M Dyer; D Catovsky
Journal:  Leukemia       Date:  1997-07       Impact factor: 11.528

Review 3.  Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review.

Authors:  Nnenna Osuji; Estella Matutes; Daniel Catovsky; Irvin Lampert; Andrew Wotherspoon
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

4.  High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.

Authors:  C E Dearden; E Matutes; B Cazin; G E Tjønnfjord; A Parreira; B Nomdedeu; P Leoni; F J Clark; D Radia; S M Rassam; T Roques; N Ketterer; V Brito-Babapulle; M J Dyer; D Catovsky
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

5.  Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.

Authors:  Y Pekarsky; C Hallas; M Isobe; G Russo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  T-cell Prolymphocytic Leukemia.

Authors: 
Journal:  Cancer Control       Date:  1998-01       Impact factor: 3.302

7.  Deregulated expression of TCL1 causes T cell leukemia in mice.

Authors:  L Virgilio; C Lazzeri; R Bichi; K Nibu; M G Narducci; G Russo; J L Rothstein; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization.

Authors:  S H Maljaei; V Brito-Babapulle; L R Hiorns; D Catovsky
Journal:  Cancer Genet Cytogenet       Date:  1998-06

Review 9.  Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia.

Authors:  V Brito-Babapulle; D Catovsky
Journal:  Cancer Genet Cytogenet       Date:  1991-08

10.  The morphological spectrum of T-prolymphocytic leukaemia.

Authors:  E Matutes; J Garcia Talavera; M O'Brien; D Catovsky
Journal:  Br J Haematol       Date:  1986-09       Impact factor: 6.998

View more
  4 in total

1.  A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.

Authors:  Luis A Figueroa-Jiménez; Amy Lee Cabrera-Márquez; Luis Báez-Díaz; William Cáceres-Perkins
Journal:  Bisturi (S Juan)       Date:  2016 Mar-Jun

2.  CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.

Authors:  Carlos Cuesta-Mateos; Patricia Fuentes; Alexandra Schrader; Raquel Juárez-Sánchez; Javier Loscertales; Tamara Mateu-Albero; Lorena Vega-Piris; Marina Espartero-Santos; Ana Marcos-Jimenez; Blanca Andrea Sánchez-López; Yaiza Pérez-García; Dennis Jungherz; Sebastian Oberbeck; Linus Wahnschaffe; Anna Kreutzman; Emma I Andersson; Satu Mustjoki; Edgar Faber; Ana Urzainqui; Manuel Fresno; Kostantino Stamatakis; Arantzazu Alfranca; Fernando Terrón; Marco Herling; María Luisa Toribio; Cecilia Muñoz-Calleja
Journal:  Biomark Res       Date:  2020-10-24

3.  T-cell Prolymphocytic Leukemia, Cerebriform Variant.

Authors:  José Carvalho; Alexandra Esteves; Francisco Teixeira da Silva; Joana Couto; Carlos Ribeiro
Journal:  Cureus       Date:  2021-02-12

4.  Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia.

Authors:  Nathan Mikhaylenko; Linus Wahnschaffe; Marco Herling; Ingo Roeder; Michael Seifert
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.